Andrew Wonhee Han
15Patents
2h-index
20Co-inventors
50Inventor score
Filing activity: May 21, 2013 → Jul 18, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10251933B2 | Proteins for the treatment of epithelial barrier function disorders | Chemistry; Metallurgy | 3 | Active |
| US8841086B2 | Kit for detecting bacterial contamination | Physics | 2 | Active |
| US9879301B2 | Rapid peptidoglycan-based assay for detection of bacterial contamination | Physics | 1 | Active |
| US11273198B2 | Proteins for the treatment of epithelial barrier function disorders | Human Necessities | 1 | Active |
| US11174293B2 | Proteins for the treatment of epithelial barrier function disorders | Chemistry; Metallurgy | 1 | Active |
| US11207376B2 | Proteins for the treatment of epithelial barrier function disorders | Chemistry; Metallurgy | 1 | Active |
| US12168676B2 | Microbially derived peptides and proteins for immunotherapy | Human Necessities | 0 | Active |
| US10570438B2 | Rapid peptidoglycan-based assay for detection of bacterial contamination | Physics | 0 | Active |
| US11505583B2 | Proteins for the treatment of epithelial barrier function disorders | Chemistry; Metallurgy | 0 | Active |
| US11666627B2 | Proteins for the treatment of epithelial barrier function disorders | Chemistry; Metallurgy | 0 | Active |
| US12186364B2 | Proteins for the treatment of epithelial barrier function disorders | Human Necessities | 0 | Active |
| US11389487B2 | Streptococcus australis as a biotherapeutic | Chemistry; Metallurgy | 0 | Active |
| US12168677B2 | Proteins for the treatment of epithelial barrier function disorders | Chemistry; Metallurgy | 0 | Active |
| US12371456B2 | Proteins for the treatment of epithelial barrier function disorders | Human Necessities | 0 | Active |
| US11344584B2 | Gemella sanguinis as a biotherapeutic | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.